Shares of Carrols Restaurant Group experienced a significant surge on Tuesday after Restaurant Brands International, the parent company of Burger King, announced its plans to acquire the company. In pre-market trading, the stock rose by 13% to reach $9.50, marking a fourfold increase over the past year.

Restaurant Brands International (RBI) has agreed to pay $9.55 per share for Carrols, resulting in an enterprise value of approximately $1 billion. As the largest Burger King franchisee in the U.S., Carrols operates more than 1,000 locations. In addition, the company owns and manages 60 Popeyes restaurants.

RBI revealed that the purchase price represents a 13.4% premium on Carrols' closing price on January 12th and a 23% premium on the stock's 30-day volume weighted average price as of the same date. Notably, Carrols' Burger King restaurants achieved system sales of around $1.8 billion in the year ending September 30th.

In contrast to Carrols' stock surge, shares of Restaurant Brands experienced a slight decline of 1.1% in pre-market trading, falling to $77.58.

Oil Prices Rebound Amidst Concerns Over Energy Demand and Attacks on Tanker Ships

Shares of Boeing Co. Enter "Bear-Market" Territory

Leave A Reply

Your email address will not be published. Required fields are marked *

Related posts

Thailand Stock Market Decline
News

Thailand Stock Market Decline

The Thai stock market saw a decline, with some companies facing significant drops. Other markets in Southeast Asia also...

Taiwan Semiconductor Manufacturing Shows Strong Performance in September Quarter
News

Taiwan Semiconductor Manufacturing Shows Strong Performance in September Quarter

Taiwan Semiconductor Manufacturing (TSM) has reported strong sales figures for September quarter, surpassing analyst exp...

Most Admired Companies: Are Popular Stocks the Best Investments?
News

Most Admired Companies: Are Popular Stocks the Best Investments?

Fortune's Most Admired Companies often underperform in the stock market. Popularity doesn't equal profitability. Look be...

RedHill Biopharma Reports Positive Results in Ebola Virus Study
News

RedHill Biopharma Reports Positive Results in Ebola Virus Study

RedHill Biopharma announces positive results in an Ebola virus study, showing the synergistic effect of opaganib and RHB...